Glomerulonephritis Classification

Understanding how to classify glomerular diseases is a cornerstone of nephrology and essential for clinical reasoning. It moves you from recognizing a patient's symptoms to identifying the underlying pathological process, which directly dictates treatment and predicts outcomes. This framework centers on distinguishing between two fundamental clinical syndromes—nephritic and nephrotic—and then delves into the specific diseases that cause them, each with its own unique mechanism and implications.

The Foundational Dichotomy: Nephritic vs. Nephrotic Syndromes

The first critical step is separating nephritic syndrome from nephrotic syndrome. While some diseases can have overlapping features, this dichotomy provides the initial diagnostic compass.

Nephritic syndrome is characterized by inflammation within the glomerulus. Think of it as an active "fire" damaging the filtration barrier, particularly affecting the endothelial cells and the basement membrane. This inflammatory damage allows red blood cells to leak into the urine, causing hematuria (often visibly cola-colored). The inflamed glomeruli also impair blood flow, triggering the renin-angiotensin-aldosterone system and leading to hypertension and fluid retention (edema). Proteinuria is present but is typically sub-nephrotic (less than 3.5 g/day). The hallmark is, therefore, hematuria, hypertension, mild-to-moderate proteinuria, and possibly reduced urine output (oliguria) and elevated serum creatinine.

In contrast, nephrotic syndrome results from a structural or functional podocyte injury, without prominent inflammation. Imagine the podocyte foot processes, which form the final filtration barrier, becoming "leaky." This leads to massive loss of protein, specifically albumin, into the urine—heavy proteinuria (greater than 3.5 g/day). The consequent low blood albumin (hypoalbuminemia) reduces plasma oncotic pressure, causing severe generalized edema. Hematuria and hypertension are not primary features, though they may occur in some nephrotic diseases. Key laboratory findings include hypoalbuminemia, hyperlipidemia, and lipiduria.

Primary Nephrotic Syndromes: Podocyte Pathology

This group of diseases primarily presents with nephrotic syndrome. The key is identifying the specific podocyte pathology.

Minimal Change Disease (MCD) is the most common cause of nephrotic syndrome in children. The name comes from its histology: under a light microscope, the glomeruli appear normal ("minimal change"). The pathology is only visible under an electron microscope, which reveals diffuse effacement (flattening) of podocyte foot processes. It is thought to be mediated by a T-cell cytokine that damages the podocytes. Its classic presentation is sudden-onset severe edema in a child following an upper respiratory infection. It is highly responsive to corticosteroid therapy.

Focal Segmental Glomerulosclerosis (FSGS) describes scarring (sclerosis) that affects only some glomeruli (focal) and only portions of each affected glomerulus (segmental). It involves podocyte injury and depletion. The scarred segments trap plasma proteins, leading to prominent proteinuria. FSGS can be primary (idiopathic) or secondary to factors like obesity, HIV, or drug toxicity. It is a major cause of nephrotic syndrome in adults and is often steroid-resistant, frequently progressing to end-stage kidney disease.

Membranous Nephropathy is a common cause of nephrotic syndrome in non-diabetic adults. Here, the pathology is in the glomerular basement membrane (GBM). Immune complexes (typically antibodies against the podocyte antigen PLA2R) deposit on the subepithelial side of the GBM. Over time, the membrane thickens as it attempts to incorporate these deposits, visible on microscopy as "spikes." This thickened, leaky membrane causes severe proteinuria. About one-third of cases are secondary to malignancies, infections, or autoimmune diseases like lupus.

Primary Nephritic Syndromes: Inflammatory Insults

These diseases typically present with nephritic syndrome, driven by immune-mediated inflammation.

IgA Nephropathy (Berger's disease) is the most common glomerulonephritis worldwide. Its mechanism involves the deposition of immunoglobulin A (IgA) in the mesangium of the glomerulus. This is often triggered by mucosal infections (e.g., upper respiratory or gastrointestinal), leading to the production of galactose-deficient IgA1. The immune complexes activate complement and incite mesangial proliferation. The classic presentation is synchronous gross hematuria within 1-2 days of an infection, unlike the 1-3 week lag seen in post-streptococcal disease. It can range from mild, recurrent hematuria to rapidly progressive disease.

Post-Streptococcal Glomerulonephritis (PSGN) is a classic example of an immune-complex-mediated nephritis. It occurs 1-3 weeks after an infection with specific nephritogenic strains of Group A Streptococcus. Antibodies produced against the bacterial antigens form circulating immune complexes that get trapped in the glomeruli, typically on the subendothelial side of the GBM. This triggers complement activation (low C3 levels) and a diffuse proliferative inflammatory response. It commonly presents in children with the acute nephritic syndrome: hematuria, edema, hypertension, and oliguria following a sore throat or impetigo. Most cases in children resolve spontaneously.

Crescentic Glomerulonephritis: A Medical Emergency

When nephritic inflammation becomes severe, it can damage the capillary walls so extensively that fibrin, inflammatory cells, and proliferating parietal epithelial cells fill Bowman's space, forming crescents. The presence of many crescents (in >50% of glomeruli) defines Crescentic Rapidly Progressive Glomerulonephritis (RPGN), characterized by a rapid loss of kidney function over days to weeks.

RPGN is classified by the underlying immune mechanism:

• Type I (Anti-GBM disease): Antibodies directly attack the collagen in the GBM. The classic example is Goodpasture syndrome, where anti-GBM antibodies also attack alveolar basement membranes, causing pulmonary hemorrhage.
• Type II (Immune-complex mediated): Severe versions of diseases like lupus nephritis, IgA nephropathy, or PSGN, where extensive immune-complex deposition drives crescent formation.
• Type III (Pauci-immune): Little to no immune complex deposition is seen; it is mediated by anti-neutrophil cytoplasmic antibodies (ANCA) that activate neutrophils to attack the glomerular capillaries. This includes diseases like granulomatosis with polyangiitis.

All types of RPGN require immediate diagnosis via kidney biopsy and aggressive immunosuppressive therapy to salvage kidney function.

Common Pitfalls

1. Confusing the timing of hematuria: A classic trap is misidentifying the cause of hematuria. Remember, hematuria that appears synchronously (within 1-2 days) with a mucosal infection points strongly toward IgA Nephropathy. Hematuria that appears after a lag of 1-3 weeks points toward Post-Streptococcal GN. Knowing this detail can steer your initial diagnostic hypothesis.

1. Assuming all edema with proteinuria is primary nephrotic syndrome: A patient with new edema and proteinuria might have nephrotic syndrome, but you must first rule out secondary causes. For an adult with new membranous nephropathy, you must screen for underlying malignancy (e.g., lung, GI cancers). For a patient with FSGS, consider secondary causes like obesity, HIV, or sickle cell disease before labeling it as primary/idiopathic.

1. Overlooking the urgency of RPGN: Not all glomerulonephritis progresses slowly. Failing to recognize the signs of Rapidly Progressive GN—a rapid rise in serum creatinine over days/weeks, often with nephritic sediment and possibly oliguria—is a critical error. This is a nephrological emergency requiring immediate biopsy and treatment to prevent irreversible kidney failure.

1. Mislocating the immune deposits: While biopsy interpretation is for pathologists, conceptually understanding where immune complexes deposit helps explain disease mechanisms. Subepithelial deposits (between podocyte and GBM) are classic for Membranous Nephropathy and cause heavy proteinuria. Subendothelial deposits (between endothelium and GBM) and mesangial deposits are seen in inflammatory nephritic diseases like Lupus Nephritis or IgA Nephropathy, and are more associated with hematuria and active inflammation.

Summary

• The primary clinical classification divides glomerular diseases into nephritic syndrome (hematuria, hypertension, inflammatory podocyte pathology) and nephrotic syndrome (heavy proteinuria >3.5g/day, edema, structural podocyte pathology).
• Key nephrotic diseases include Minimal Change Disease (podocyte foot process effacement), Focal Segmental Glomerulosclerosis (focal scarring), and Membranous Nephropathy (subepithelial immune deposits causing GBM thickening).
• Key nephritic diseases include IgA Nephropathy (mesangial IgA deposits causing synchronous hematuria) and Post-Streptococcal GN (post-infectious immune complexes with a 1-3 week lag).
• Crescentic Rapidly Progressive Glomerulonephritis is a severe, rapidly deteriorating condition defined by crescents in Bowman's space and classified by mechanism into anti-GBM, immune-complex, or pauci-immune (ANCA-associated) types.
• Accurate classification hinges on integrating clinical presentation (syndrome), urinalysis findings, serology, and understanding of the underlying pathological mechanism to guide appropriate management and predict prognosis.